CN105037428A - Preparation method for coumarin-3-phosphonate derivative - Google Patents
Preparation method for coumarin-3-phosphonate derivative Download PDFInfo
- Publication number
- CN105037428A CN105037428A CN201510406290.4A CN201510406290A CN105037428A CN 105037428 A CN105037428 A CN 105037428A CN 201510406290 A CN201510406290 A CN 201510406290A CN 105037428 A CN105037428 A CN 105037428A
- Authority
- CN
- China
- Prior art keywords
- coumarin
- preparation
- phosphonate derivative
- derivative
- following group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(C)OP(C(C(Cc1c2)=*)=C(C)c1ccc2O)(OC(C)C)=O Chemical compound CC(C)OP(C(C(Cc1c2)=*)=C(C)c1ccc2O)(OC(C)C)=O 0.000 description 1
- OPOHYSPAZBNWAM-UHFFFAOYSA-N CC(C)OP(C1=Cc2ccccc2OC1=O)(OC(C)C)=O Chemical compound CC(C)OP(C1=Cc2ccccc2OC1=O)(OC(C)C)=O OPOHYSPAZBNWAM-UHFFFAOYSA-N 0.000 description 1
- JCHUODUQMLVONH-UHFFFAOYSA-N CCCO[O](C1=Cc2ccccc2OC1=O)(OCCC)=O Chemical compound CCCO[O](C1=Cc2ccccc2OC1=O)(OCCC)=O JCHUODUQMLVONH-UHFFFAOYSA-N 0.000 description 1
Abstract
The invention discloses a preparation method for a coumarin-3-phosphonate derivative (I) and belongs to the field of organic chemistry. By taking a substituted coumarin derivative and phosphite ester as raw materials, the coumarin-3-phosphonate derivative is synthesized under the joint action of an AgNO3 catalyst and an adjuvant. The raw materials are low in price and are easily available, the reaction condition is wild, the operation is simple and convenient, the synthetic yield is high, and industrial production is facilitated. The derivative has potential application in the field of materials, chemical engineering, medicines and the like. The preparation method disclosed by the invention provides a novel path for synthesizing the coumarin-3-phosphonate derivative. The formula is shown in the description.
Description
Technical field
The present invention relates to a kind of preparation method of coumarin-3-phosphonate derivative, belong to organic chemistry filed.
Background technology
Tonka bean camphor is the important natural product of a class, and its derivative has biological activity widely, as antimicrobial antiphlogistic, anti-senile dementia, AntiHIV1 RT activity and anti-thymic carcinoma etc.The phosphonylation tonka bean camphor of 3-, as the phosphorous derivant of tonka bean camphor, has good cytotoxicity to the leukemia cell of the mankind, and therefore, the synthesis of the phosphonylation coumarin derivatives of research 3-has important practical significance.
At present, the synthesis of coumarin-3-phosphonate derivative adopts Knoevenagel to react usually or Arbuzov reaction realizes, but these methods need polystep reaction and condition is relatively harsh, lacks economy and practicality.Document " ZhouP, JiangYJ, ZouJP, etal.Mn (OAc)
3-mediatedfreeradicalphosphonylationofflavonesandcoumarins [J] .Synthesis, 2012,44:1043-1050. " and " Zou Jianping, Jiang Yaojia, Pan Xiangqiang. a kind of method [P] .CN101497632A of synthesizing coumarin-3-phosphonate derivative " with Mn (OAc)
3for catalyzer, lipid acid is solvent, and tonka bean camphor and phosphite reactions obtain the phosphonylation coumarin derivatives of 3-.Document " MiX; HuangMM; ZhangJY; etal.Regioselectivepaddadium-catalyzedphosphonationofcou marinswithdialkylH-phosphonatesviaC-Hfunctionalization [J] .OrgLett; 2013,15 (24): 6266-6269. " is catalyzer with metal Pd, 2,2 '-dipyridyls etc. are part, K
2s
2o
8for oxygenant, tonka bean camphor and phosphorous acid ester obtain the phosphonylation coumarin derivatives of 3-by metal activation 3 hydrogen.Document " MiX; WangCY; HuangMM; etal.Silver-catalyzedsynthesisof3-phosphoratedcoumarinsv iaradicalcyclizationofalkynoatesanddialkylH-phosphonates [J] .OrgLett; 2014,16 (12): 3356-3359. " is with Ag
2cO
3for catalyzer, with alkynes ester for raw material, obtain the phosphonylation coumarin derivatives of 3-with phosphorous acid ester by free radical reaction.But these synthetic methods need acid to make solvent, or use precious metal to be catalyzer, or use the shortcomings such as the reacting precursor that is difficult to obtain.Therefore; be badly in need of inquiring into a kind of step simple, mild condition, the synthetic method of the coumarin-3-phosphonate derivative that yield is higher; this will promote the exploitation of coumarin-3-phosphonate derivative, has great importance to the research and development of protection China independent intellectual property right.
Summary of the invention
Based on above-mentioned research background, the object of the present invention is to provide a kind of mild condition, yield high, obtained the new synthetic method of coumarin-3-phosphonate derivative by single step reaction.
For realizing the object of the invention, the present invention with substituted cumarin and phosphorous acid ester for raw material, at catalyst A gNO
3with synthesizing coumarin-3-phosphonate derivative under auxiliary acting in conjunction.Coumarin-3-phosphonate derivative of the present invention has following general formula I.
Wherein R represents following group: C1-5 alkyl, phenyl or benzyl, preferably-CH
3,-C
2h
5,-CH
2cH
2cH
3,-CH (CH
3)
2; R
1represent one of hydrogen base or following group: methyl, ethyl, methoxy or ethoxy, preferably-H ,-CH
3,-OCH
3; R
2represent hydrogen base or following group monosubstituted or two replacement on phenyl ring: methyl, ethyl, methoxyl group, oxyethyl group, nitro, amino, hydroxyl, kharophen, acetoxyl group or halogen, R
2be preferably as follows group monosubstituted on phenyl ring :-F ,-Cl ,-Br ,-CH
3,-C
2h
5,-OCH
3,-OC
2h
5,-OH ,-NH
2,-NHCOCH
3.
Concrete technical scheme realizes as follows: be first dissolved in suitable organic solvent by substituted cumarin A and phosphorous acid ester B, then add catalyst A gNO
3and auxiliary, react at 80-100 DEG C.After reaction terminates, be cooled to room temperature, through washing, extraction, dry, pressure reducing and steaming solvent, obtains general formula (I) coumarin-3-phosphonate derivative crude product.
The preferred 1:2 of mol ratio of substituted cumarin A and phosphorous acid ester B.Catalyst A gNO
3amount be 5% of substituted cumarin molar weight.
Mg (NO selected by auxiliary
3)
26H
2o, Fe (NO
3)
39H
2o, NaNO
3, Cu (NO
3)
23H
2o, Cr (NO
3)
39H
2o, preferred Mg (NO
3)
26H
2o is as auxiliary, and the amount added is 50% of substituted cumarin molar weight.
In organic solvent selection THF, toluene, dioxane, methyl alcohol, chloroform, DMSO and acetonitrile etc., one or more are as solvent, and preferred acetonitrile is solvent.Preferred employing 90 DEG C is best temperature of reaction, and the best reaction times is 5h.
R, R in formula
1, R
2state the same.
Abstraction and purification coumarin-3-phosphonate derivative crude product, such as, is undertaken being separated to obtain coumarin-3-phosphonate derivative (I) by silica gel column chromatography by crude product, makes it obtain better application.In addition, by adding appropriate sherwood oil in the ethyl acetate solution of (I), (I) crystallization can be made.This analog derivative has potential application in material, chemical industry, medicine and other fields.
Agents useful for same of the present invention all commercially.
The principle of the invention is: first phosphorous acid ester reacts with Silver Nitrate and generate intermediate ((CH
3)
2cHO)
2p (O) Ag mixture, sloughs Ag (0) and forms phosphorus free radical afterwards; Then 3 carbon atoms of phosphorus free radical attack tonka bean camphor, form carbon radicals, by Ag (I) effect, obtain an electronics and form Ag (0), thus form a carbonium ion; Target product coumarin-3-phosphonate derivative is obtained finally by cancellation proton.
Beneficial effect of the present invention is: the method cheaper starting materials of synthesizing coumarin-3-phosphonate derivative of the present invention is easy to get, reaction conditions gentle, obtain target compound by single step reaction, easy and simple to handle, synthetic yield is high, reach more than 60%, be very beneficial for suitability for industrialized production, for preparation there is antimicrobial antiphlogistic, the coumarin-3-phosphonate derivative of anticancer isoreactivity provides a new approach.
Embodiment
Below by embodiment, the present invention will be further elaborated, but and do not mean that content limitation of the present invention is in embodiment.
Embodiment 1.R=-CH (CH
3)
2, R
1=R
2during=-H, the preparation of tonka bean camphor-3-di-isopropyl phosphate derivatives
Tonka bean camphor (0.5mmol, 73mg) is added and diisopropyl phosphite (1.0mmol, 166mg) is dissolved in 3.0mLCH in 10mL reaction flask
3in CN, then add AgNO
3(0.025mmol, 4.2mg) and Mg (NO
3)
26H
2o (0.25mmol, 64mg).React under heated and stirred in oil bath, temperature of reaction is 90 DEG C.By TLC tracking reaction process, the reaction times is 5h, after reaction terminates, removes solvent under reduced pressure, adds 10mL ethyl acetate in raffinate, with the NaHCO that 20mL is saturated
3washing secondary, then the brine It using 10mL saturated is once, purifies (eluent: ethyl acetate/petroleum ether=1/5), obtain white solid 0.096g, productive rate 62.0% after solution is concentrated with silica gel column chromatography.
Fusing point 95-96 DEG C.
1hNMR (CDCl
3) δ: 8.49 (d, J
p-H=6.9Hz, 1H), 7.62-7.55 (m, 2H), 7.32-7.28 (m, 2H), 4.87-4.79 (m, 2H), 1.34 (dd, J
p-H=12.9Hz, J
h-H=6.0Hz, 12H).
13cNMR (CDCl
3) δ: 158.1 (d, J
p-C=22.9Hz), 155.2,152.9 (d, J
p-C=10.7Hz), 134.0,129.3,124.8,119.8,118.0 (d, J
p-C=22.7Hz), 116.8,72.2 (d, J
p-C=9.8Hz), 24.0 (d, J
p-C=6.8Hz), 23.8 (d, J
p-C=7.6Hz).
31pNMR (CDCl
3) δ: 8.2.IR (KBr) ν (cm
-1): 2981,2935 (-CH
3), 1738 (C=O), 1614,1566 (Ar-), 1450 (P-C), 1248 (P=O), 1105 (P-O) .ESIMS311.3 [M+H]
+(calculatedforC
15h
20o
5p
+311.1).
Embodiment 2.R=-CH
2cH
2cH
3, R
1=-H, R
2during=-H, the preparation of tonka bean camphor-3-diη-propyl phosphate derivatives
In 10mL reaction flask, add tonka bean camphor (0.5mmol, 73mg) and di-n-propyl phosphite (1.0mmol, 166mg) is dissolved in 3.0mL chloroform, then add AgNO
3(0.025mmol, 4.2mg) and Fe (NO
3)
39H
2o (0.25mmol, 101mg).React under heated and stirred in oil bath, temperature of reaction is 80 DEG C.By TLC tracking reaction process, the reaction times is 5h, after reaction terminates, removes solvent under reduced pressure, adds 10mL ethyl acetate in raffinate, with the NaHCO that 20mL is saturated
3washing secondary, then the brine It using 10mL saturated is once, purifies (eluent: ethyl acetate/petroleum ether=1/5), obtain faint yellow viscous liquid 0.093g, productive rate 60.0% after solution is concentrated with silica gel column chromatography.
1HNMR(CDCl
3)δ:8.50(d,J
P-H=6.9Hz,1H),7.64-7.56(m,2H),7.34-7.29(m,2H),4.20-4.06(m,4H),1.76-1.68(m,4H),0.94(d,J
H-H=7.4Hz,6H).
13CNMR(CDCl
3)δ:158.1(d,J
P-C=23.4Hz),155.2,153.4(d,J
P-C=10.5Hz),134.2,129.3,124.9,118.8,117.9(d,J
P-C=22.7Hz),116.8,68.8(d,J
P-C=10.2Hz),23.8(d,J
P-C=10.4Hz),10.0.
31PNMR(CDCl
3)δ:10.5.IR(KBr)ν(cm
-1):2968,2931,2850(-CH
3,-CH
2),1732(C=O),1610,1564(Ar-),1445(P-C),1248(P=O),1008(P-O).ESIMS311.2[M+H]
+(calculatedforC
15H
20O
5P
+311.1).
Embodiment 3.R=-CH (CH
3)
2, R
1=-H, R
2=-OCH
3time, the preparation of ayapanin-3-di-isopropyl phosphate derivatives
In 25mL reaction flask, add ayapanin (1.0mmol, 176mg) and diisopropyl phosphite (2.0mmol, 232mg) is dissolved in 5.0mL methyl alcohol, then add AgNO
3(0.05mmol, 8.4mg) and NaNO
3(0.5mmol, 42.5mg).React under heated and stirred in oil bath, temperature of reaction is 90 DEG C.By TLC tracking reaction process, the reaction times is 5h, after reaction terminates, removes solvent under reduced pressure, adds 10mL ethyl acetate in raffinate, with the NaHCO that 20mL is saturated
3washing secondary, then the brine It using 10mL saturated is once, purifies (eluent: ethyl acetate/petroleum ether=1/3), obtain white solid 0.216g, productive rate 64.0% after solution is concentrated with silica gel column chromatography.
Fusing point 76-77 DEG C.
1hNMR (CDCl
3) δ: 8.37 (d, J
p-H=6.8Hz, 1H), 7.42 (d, J
h-H=8.7Hz, 1H), 6.82 (dd, J
h-H=2.4Hz, J
h-H=8.7Hz, 1H), 6.74 (d, J
h-H=2.4Hz, 1H), 4.80-4.72 (m, 2H), 1.33 (d, J
h-H=6.2Hz, 6H), 1.26 (d, J
h-H=6.2Hz, 6H).
13cNMR (CDCl
3) δ: 164.7,158.4 (d, J
p-C=23.7Hz), 157.4,152.9 (d, J
p-C=11.3Hz), 130.4,113.2 (d, J
p-C=16.6Hz), 111.7 (d, J
p-C=23.2Hz), 100.5,71.9 (d, J
p-C=9.6Hz), 55.9,24.0 (d, J
p-C=6.5Hz), 23.8 (d, J
p-C=7.5Hz).
31pNMR (CDCl
3) δ: 8.8.IR (KBr) ν (cm
-1): 2981,2935 (-CH
3), 1738 (C=O), 1614,1553 (Ar-), 1373 (P-C), 1252 (P=O), 1142 (P-O) .ESIMS341.3 [M+H]
+(calculatedforC
16h
22o
6p
+341.1).
Embodiment 4.R=-CH (CH
3)
2, R
1=-H, R
2=-NO
2time, the preparation of 6-nitro tonka bean camphor-3-di-isopropyl phosphate derivatives
In 25mL reaction flask, add 6-nitro tonka bean camphor (1.0mmol, 191mg) and diisopropyl phosphite (2.0mmol, 232mg) is dissolved in 5.0mL dioxane, then add AgNO
3(0.05mmol, 8.4mg) and Cr (NO
3)
39H
2o (0.5mmol, 200mg).React under heated and stirred in oil bath, temperature of reaction is 100 DEG C.By TLC tracking reaction process, the reaction times is 5h, after reaction terminates, removes solvent under reduced pressure, adds 10mL ethyl acetate in raffinate, with the NaHCO that 20mL is saturated
3washing secondary, then the brine It using 10mL saturated is once, purifies (eluent: ethyl acetate/petroleum ether=2/1), obtain faint yellow viscous liquid 0.212g, productive rate 60.0% after solution is concentrated with silica gel column chromatography.
1HNMR(CDCl
3)δ:8.56(d,J
P-H=5.9Hz,1H),8.54(s,1H),8.48(dd,J
H-H=2.6Hz,J
H-H=9.0Hz,1H),7.50(d,J
H-H=9.0Hz,1H),4.95-4.87(m,2H),1.43(d,J
H-H=6.2Hz,6H),1.35(d,J
H-H=6.2Hz,6H).
13CNMR(CDCl
3)δ:158.4,156.5(d,J
P-C=22.3Hz),150.9(d,J
P-C=10.5Hz),144.1,128.2,124.9,122.9,121.0,118.1,118.0(d,J
P-C=23.5Hz),72.8(d,J
P-C=10.2Hz),24.0(d,J
P-C=6.5Hz),23.8(d,J
P-C=6.5Hz).
31PNMR(CDCl
3)δ:5.6.IR(KBr)ν(cm
-1):3087,2965(-CH
3,),1735(C=O),1625,1578(Ar-),1376(P-C),1245(P=O),1134(P-O).ESIMS356.1[M+H]
+(calculatedforC
15H
19NO
7P
+356.0).
Embodiment 5.R=-CH (CH
3)
2, R
1=-CH
3, R
2during=-OH, the preparation of AP20am16-3-di-isopropyl phosphate derivatives
AP20am16 (1.0mmol, 176mg) is added and diisopropyl phosphite (2.0mmol, 232mg) is dissolved in 5.0mLCH in 25mL reaction flask
3in CN, then add AgNO
3(0.05mmol, 8.4mg) and Cu (NO
3)
23H
2o (0.5mmol, 120.5mg).React under heated and stirred in oil bath, temperature of reaction is 90 DEG C.By TLC tracking reaction process, the reaction times is 5h, after reaction terminates, removes solvent under reduced pressure, adds 10mL ethyl acetate in raffinate, with the NaHCO that 20mL is saturated
3washing secondary, then the brine It using 10mL saturated is once, purifies (eluent: ethyl acetate/petroleum ether=5/1), obtain faint yellow viscous liquid 0.21g, productive rate 62.0% after solution is concentrated with silica gel column chromatography.
1HNMR(CDCl
3)δ:10.1(s,-OH),7.64(d,J
H-H=8.9Hz,1H),6.94(dd,J
H-H=2.4Hz,J
H-H=8.9Hz,1H),6.89(d,J
H-H=2.4Hz,1H),4.89-4.80(m,2H),2.90(d,J
P-H=0.9Hz,3H),1.40(d,J
H-H=6.2Hz,6H),1.33(d,J
H-H=6.2Hz,6H).
13CNMR(CDCl
3)δ:163.4(d,J
P-C=20.8Hz),159.5(d,J
P-C=25.3Hz),155.7,127.5,114.1,112.6(d,J
P-C=25.2Hz),111.1,109.1,102.8,72.4(d,J
P-C=10.0Hz),24.0(d,J
P-C=7.4Hz),23.8(d,J
P-C=7.4Hz),17.1(d,J
P-C=6.2Hz).
31PNMR(CDCl
3)δ:10.0.IR(KBr)ν(cm
-1):3105(-OH),2993,2905(-CH
3),1736(C=O),1599,1482(Ar-),1352(P-C),1198(P=O),1005(P-O).ESIMS341.2[M+H]
+(calculatedforC
16H
22O
6P
+341.1).
Embodiment 6.R=-CH (CH
3)
2, R
1=-CH
3, R
2=-OC
2h
5time, the preparation of 4-methyl-CYP1A-3-di-isopropyl phosphate derivatives
In 25mL reaction flask, add 4-methyl-CYP1A (1.0mmol, 204mg) and diisopropyl phosphite (2.0mmol, 232mg) is dissolved in 5.0mL toluene, then add AgNO
3(0.05mmol, 8.4mg) and Mg (NO
3)
26H
2o (0.5mmol, 128mg).React under heated and stirred in oil bath, temperature of reaction is 90 DEG C.By TLC tracking reaction process, the reaction times is 5h, after reaction terminates, removes solvent under reduced pressure, adds 10mL ethyl acetate in raffinate, with the NaHCO that 20mL is saturated
3washing secondary, then the brine It using 10mL saturated is once, purifies (eluent: ethyl acetate/petroleum ether=5/1), obtain clear crystal 0.24g, productive rate 68.0% after solution is concentrated with silica gel column chromatography.
Fusing point 83-84 DEG C.
1hNMR (CDCl
3) δ: 7.70 (dd, J
h-H=4.7Hz, J
h-H=8.6Hz, 1H), 6.87-6.85 (m, 1H), 6.74 (d, J
h-H=2.5Hz, 1H), 4.83-4.80 (m, 2H), 4.12-4.09 (m, 2H), 2.96 (d, J
p-H=1.1Hz, 3H), 1.45 (d, J
h-H=5.5Hz, 1H), 1.41-1.38 (m, 6H), 1.33-1.30 (m, 6H).
13cNMR (CDCl
3) δ: 163.4,162.6 (d, J
p-C=17.1Hz), 158.8 (d, J
p-C=23.3Hz), 155.6,127.2,113.5 (d, J
p-C=25.8Hz), 113.1,111.2,100.6,71.6 (d, J
p-C=9.7Hz), 64.3,24.0 (d, J
p-C=7.2Hz), 23.9 (d, J
p-C=7.2Hz), 16.8 (d, J
p-C=5.7Hz), 14.4.
31pNMR (CDCl
3) δ: 10.2.IR (KBr) ν (cm
-1): 3096,2967,2855 (-CH
3,-CH
2), 1735 (C=O), 1562,1480 (Ar-), 1340 (P-C), 1178 (P=O), 1025 (P-O) .ESIMS369.2 [M+H]
+(calculatedforC
18h
26o
6p
+369.1).
Embodiment 7.R=-CH (CH
3)
2, R
1=-H, R
2=-OCH
3time, the preparation of 6,7-escoparone-3-di-isopropyl phosphate derivatives
6,7-escoparone (1.0mmol, 204mg) is added and diisopropyl phosphite (2.0mmol, 232mg) is dissolved in 5.0mLCH in 25mL reaction flask
3in CN, then add AgNO
3(0.05mmol, 8.4mg) and Mg (NO
3)
26H
2o (0.5mmol, 128mg).React under heated and stirred in oil bath, temperature of reaction is 90 DEG C.By TLC tracking reaction process, the reaction times is 5h, after reaction terminates, removes solvent under reduced pressure, adds 10mL ethyl acetate in raffinate, with the NaHCO that 20mL is saturated
3washing secondary, then the brine It using 10mL saturated is once, purifies (eluent: ethyl acetate/petroleum ether=2/1), obtain white solid 0.277g, productive rate 75.0% after solution is concentrated with silica gel column chromatography.
Fusing point 196-198 DEG C.
1hNMR (CDCl
3) δ: 8.43 (d, J=16.9Hz), 6.9 (s, 1H), 6.84 (s, 1H), 4.87-4.47 (m, 2H), 3.98 (s, 3H, OCH
3), 3.93 (s, 3H, OCH
3), 1.41 (d, J=6.2Hz, 6H), 1.33 (d, J=6.2Hz, 6H).
13cNMR (CDCl
3): δ 158.70 (d, J=14.4Hz), 154.96,152.78 (d, J=7.0Hz), 152.03,146.71,114.67 (d, J=197.2Hz), 110.79 (d, J=14.5Hz), 108.69,99.69,72.02 (d, J=6.0Hz), 56.59,56.41,24.10 (d, J=4.2Hz), 23.89 (d, J=4.7Hz).
31pNMR (CDCl
3) δ: 9.96.IR (KBr) ν (cm
-1): 2980,2934 (-CH
3), 1740 (C=O), 1615,1554 (Ar-), 1368 (P-C), 1250 (P=O), 1138 (P-O) .ESIMS:m/z371.1 ([M+H]
+, C
17h
24o
7p
+calcd.371.1)..
Claims (3)
1. such as formula a preparation method for coumarin-3-phosphonate derivative (I) Suo Shi, it is characterized in that, synthesize as follows: first substituted cumarin derivative A and phosphorous acid ester B is dissolved in organic solvent, then add catalyst A gNO
3and auxiliary, react at 80-100 DEG C; After reaction terminates, be cooled to room temperature, through washing, extraction, dry, pressure reducing and steaming solvent, obtains general formula (I) coumarin-3-phosphonate derivative crude product;
Wherein R represents following group: C1-5 alkyl, phenyl or benzyl; R
1represent following group: hydrogen base, methyl, ethyl, methoxy or ethoxy; R
2represent hydrogen base or monosubstituted or disubstituted following group on phenyl ring: methyl, ethyl, methoxyl group, oxyethyl group, nitro, amino, hydroxyl, kharophen, acetoxyl group or halogen;
Described auxiliary is Mg (NO
3)
26H
2o, Fe (NO
3)
39H
2o, NaNO
3, Cu (NO
3)
23H
2o, Cr (NO
3)
39H
2o;
Described organic solvent is one or more in THF, toluene, dioxane, methyl alcohol, chloroform, DMSO or acetonitrile.
2. the preparation method of coumarin-3-phosphonate derivative according to claim 1, is characterized in that,
R choosing-CH
3,-C
2h
5,-CH
2cH
2cH
3,-CH (CH
3)
2; R
1select following group :-H ,-CH
3,-OCH
3; R
2mono-substituted following group on phenyl ring :-F ,-Cl ,-Br ,-CH
3,-C
2h
5,-OCH
3,-OC
2h
5,-OH ,-NH
2,-NHCOCH
3.
3. the preparation method of coumarin-3-phosphonate derivative according to claim 1 or 2, it is characterized in that, described reaction raw materials substituted cumarin A and the mol ratio of phosphorous acid ester B are 1:2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510406290.4A CN105037428B (en) | 2015-07-10 | 2015-07-10 | Preparation method for coumarin-3-phosphonate derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510406290.4A CN105037428B (en) | 2015-07-10 | 2015-07-10 | Preparation method for coumarin-3-phosphonate derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105037428A true CN105037428A (en) | 2015-11-11 |
CN105037428B CN105037428B (en) | 2017-01-25 |
Family
ID=54444446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510406290.4A Active CN105037428B (en) | 2015-07-10 | 2015-07-10 | Preparation method for coumarin-3-phosphonate derivative |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105037428B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105566384A (en) * | 2016-01-15 | 2016-05-11 | 河南工程学院 | Method for preparing (E)-2-aryl-alpha, beta-unsaturated carbonyl phosphonate derivative |
CN107955037A (en) * | 2017-11-21 | 2018-04-24 | 哈尔滨工业大学 | A kind of preparation method of benzenephosphonic acid ester derivant |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008209361A (en) * | 2007-02-28 | 2008-09-11 | Nobuaki So | Lipid membrane localized fluorescent probe |
CN101497632A (en) * | 2009-03-04 | 2009-08-05 | 苏州大学 | Method for synthesizing coumarin-3-phosphonate derivative |
CN103254236A (en) * | 2013-05-28 | 2013-08-21 | 苏州大学 | Preparation method of 4-aryl coumarin-3-phosphonate derivatives |
-
2015
- 2015-07-10 CN CN201510406290.4A patent/CN105037428B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008209361A (en) * | 2007-02-28 | 2008-09-11 | Nobuaki So | Lipid membrane localized fluorescent probe |
CN101497632A (en) * | 2009-03-04 | 2009-08-05 | 苏州大学 | Method for synthesizing coumarin-3-phosphonate derivative |
CN103254236A (en) * | 2013-05-28 | 2013-08-21 | 苏州大学 | Preparation method of 4-aryl coumarin-3-phosphonate derivatives |
Non-Patent Citations (2)
Title |
---|
XIA MI ET AL.: "Silver-Catalyzed Synthesis of 3‑Phosphorated Coumarins via Radical Cyclization of Alkynoates and Dialkyl H‑Phosphonates", 《ORGANIC LETTERS》 * |
姜耀甲: "醋酸锰引发的膦自由基选择性反应研究及其应用", 《工程科技1辑》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105566384A (en) * | 2016-01-15 | 2016-05-11 | 河南工程学院 | Method for preparing (E)-2-aryl-alpha, beta-unsaturated carbonyl phosphonate derivative |
CN107955037A (en) * | 2017-11-21 | 2018-04-24 | 哈尔滨工业大学 | A kind of preparation method of benzenephosphonic acid ester derivant |
Also Published As
Publication number | Publication date |
---|---|
CN105037428B (en) | 2017-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yam et al. | A Novel High‐Nuclearity Luminescent Gold (i)–Sulfido Complex | |
CN105859774B (en) | A kind of preparation method of phosphine benzene-like compounds | |
US20040259922A1 (en) | Epothilone derivatives, a process for their production thereof and their use | |
US5457219A (en) | Phosphorus compounds | |
US7767825B2 (en) | 2,2′,6,6′-tetraoxazolinyl biphenyl ligand and method for preparing the same | |
DE112011104615B4 (en) | Organoboron compound and method of making same | |
Recsei et al. | Synthesis of modified binol-phosphoramidites | |
Yuan et al. | Silver-catalyzed synthesis of 2-arylvinylphosphonates by cross-coupling of β-nitrostyrenes with H-phosphites | |
KR20130105778A (en) | Novel method for preparing 5-acetoxymethylfurfural using alkylammonium acetate salts | |
CN105037428A (en) | Preparation method for coumarin-3-phosphonate derivative | |
CN105566384A (en) | Method for preparing (E)-2-aryl-alpha, beta-unsaturated carbonyl phosphonate derivative | |
CA2571592C (en) | Process for preparing diisopropyl((1-(hydroxymethyl)-cyclopropyl)oxy) methylphosphonate | |
DE60209810T2 (en) | (ARYL) (AMINO) BORANESE AND METHOD FOR THE PRODUCTION THEREOF | |
Biricik et al. | New bis (diphenylphosphino) aniline derivatives: Synthesis and spectroscopic characterization | |
CN108299486A (en) | A method of cyclopropylboronic acid ester compounds are prepared based on iron catalysis | |
CN105209435A (en) | Pyridine- or pyrazine-containing compounds | |
CN109734667B (en) | Polysubstituted imidazole compound and synthesis method and application thereof | |
Taylor et al. | Spontaneous dehydrocoupling in peri-substituted phosphine–borane adducts | |
CN102977040B (en) | Method for synthesizing 2-quinoxalinyl dimethylacetal and 2-quinoxalinyl formaldehyde | |
CN1465580A (en) | Simple method for synthesizing pro-drug of compete A-4 | |
CN108409784B (en) | Preparation method of phosphorus chiral important intermediate | |
Failla et al. | SYNTHESIS AND CHARACTERIZATION OF AMINOPYRIDIN-2-YL-METHYL-PHOSPHONIC ACIDS | |
CN112110800B (en) | 3-aryl-2-propyne-1-alcohol derivative and preparation method thereof | |
CN113773294B (en) | Preparation method and application of flavone and isoflavone compounds | |
Gessner | Diphenyl [2-(phenylsulfonyl) propan-2-yl]-λ5-phosphanethione |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |